Ryder Insider Files Form 144 to Sell 5,500 Shares on NYSE
Rhea-AI Filing Summary
Ryder System, Inc. (R) submitted a Form 144 reporting a proposed sale of 5,500 common shares through Fidelity Brokerage Services with an aggregate market value of $1,028,450.72, to be executed on 08/22/2025 on the NYSE. The shares were acquired in 2024 through restricted stock vesting (totaling 4,940 shares across February 9–12), an ESPP purchase (155 shares on June 24), and a dividend reinvestment (3 shares on June 21). No securities sold by the reporting person in the past three months are reported. The filing includes the required representation about lack of undisclosed material adverse information and attests to Rule 144 compliance.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine insider sale disclosed under Rule 144: 5,500 shares for ~$1.03M; appears procedural, not a large ownership shift.
The Form 144 reports a single proposed sale of 5,500 common shares valued at $1,028,450.72 to occur on 08/22/2025 via Fidelity. Acquisition records shown are compensation-related (restricted stock vesting), dividend reinvestment, and an ESPP purchase in 2024, indicating the shares are recent insider awards and employee purchases. The filing states no sales in the prior three months and includes the standard attestation regarding material non-public information. Given the issuer has 40,790,636 shares outstanding, the proposed sale represents a very small fraction of outstanding shares, consistent with routine executive or employee liquidity activity rather than a corporate event.
TL;DR: The filing meets disclosure norms for insider sales and documents the basis of acquisition for the securities.
The submission provides required details: broker name and address, number of shares, aggregate market value, outstanding shares, acquisition dates and nature (restricted stock vesting, ESPP, dividend reinvestment), and the attestation about undisclosed material information. This level of disclosure supports transparency and Rule 144 procedural compliance. The filing does not indicate any trading plan dates or other governance actions. No additional governance concerns are evident from the disclosed facts alone.